International Patient Summary Implementation Guide
1.0.0 - STU 1

This page is part of the International Patient Summary Implementation Guide (v1.0.0: STU 1) based on FHIR R4. The current version which supercedes this version is 1.1.0. For a full list of available versions, see the Directory of published versions

Table of Contents

..0 Table of Contents
...1 International Patient Summary Implementation Guide
...2 General Principles
...3 Design Conventions and Principles
...4 Known Issues and Future Development
...5 IPS Structure
...6 Profiles defined as part of the IPS Guide
...7 Datatypes defined for this Guide
...8 Extensions
...9 Terminology artifacts defined as part of the IPS Implementation Guide
...10 Examples
...11 Downloads
...12 Copyrights
...13 Artifacts Summary
....13.1 Allergy Intolerance (IPS)
....13.2 Composition (IPS)
....13.3 Condition (IPS)
....13.4 Device (performer, observer)
....13.5 Device (IPS)
....13.6 Device Use Statement (IPS)
....13.7 DiagnosticReport (IPS)
....13.8 Imaging Study (IPS)
....13.9 Immunization (IPS)
....13.10 Media observation (Results: laboratory, media)
....13.11 Medication (IPS)
....13.12 Medication Statement (IPS)
....13.13 Observation (SH: alcohol use)
....13.14 Observation (Pregnancy: EDD)
....13.15 Observation (Pregnancy: outcome)
....13.16 Observation (Pregnancy: status)
....13.17 Observation Results: laboratory (IPS)
....13.18 Observation Results: pathology (IPS)
....13.19 Observation Results: radiology (IPS)
....13.20 Observation Results (IPS)
....13.21 Observation (SH: tobacco use)
....13.22 Organization (IPS)
....13.23 Patient (IPS)
....13.24 Practitioner (IPS)
....13.25 PractitionerRole (IPS)
....13.26 Procedure (IPS)
....13.27 Specimen (IPS)
....13.28 Codeable Concept (IPS)
....13.29 Coding with translations
....13.30 Quantity (IPS)
....13.31 Range (IPS)
....13.32 Ratio (IPS)
....13.33 SimpleQuantity (IPS)
....13.34 Condition abatement date
....13.35 Absent or Unknown Allergies - IPS
....13.36 Absent or Unknown Devices - IPS
....13.37 Absent or Unknown Immunization - IPS
....13.38 Absent or Unknown Medication - IPS
....13.39 Absent or Unknown Problems - IPS
....13.40 Absent or Unknown Procedures - IPS
....13.41 Allergy intolerance substance condition (GPS) - IPS
....13.42 Allergy intolerance substance condition - IPS
....13.43 Allergy Reaction (GPS) - IPS
....13.44 Problem Severity - IPS
....13.45 CORE Problem List Finding/Situation/Event (GPS) - IPS
....13.46 Current Smoking Status - IPS
....13.47 Pregnancy Expected Delivery Date Method - IPS
....13.48 Healthcare Professional Roles - IPS
....13.49 Medical Devices - IPS
....13.50 Medications (example) - IPS
....13.51 Medications (SNOMED CT) - IPS
....13.52 Medicine Active Substances - IPS
....13.53 Medicine Doseform - IPS
....13.54 Medicine Route of Administration - IPS
....13.55 Personal Relationship - IPS
....13.56 Pregnancies Summary - IPS
....13.57 Pregnancy Status - IPS
....13.58 Problem Type - IPS
....13.59 Procedures - IPS
....13.60 Results Radiology Measurement Observation (GPS-DICOM) - IPS
....13.61 Results Coded Values Laboratory (GPS) - IPS
....13.62 Results Coded Values Pathology (GPS) - IPS
....13.63 Results Laboratory ABO+RH Group (GPS) - IPS
....13.64 Results Laboratory Observation - IPS
....13.65 Results Laboratory Presence/Absence (GPS) - IPS
....13.66 Results Organism (GPS) - IPS
....13.67 Results Pathology Observation - IPS
....13.68 Results Radiology Observation - IPS
....13.69 Results Radiology Textual Observations (GPS-DICOM-LOINC) - IPS
....13.70 Results Specimen Collection Method (GPS) - IPS
....13.71 Results Specimen Type (GPS) - IPS
....13.72 SNOMED International Global Patient Set (GPS)
....13.73 Target Site - IPS
....13.74 Vaccine Target Diseases (GPS) - IPS
....13.75 Vaccine Target Diseases - IPS
....13.76 Vaccines (GPS) - IPS
....13.77 Vaccines - IPS
....13.78 WHO ATC - IPS
....13.79 Absent and Unknown Data - IPS
....13.80 Absence of Information Mappings - IPS to SNOMED CT
....13.81 Severity Value Set Mappings - LOINC to FHIR
....13.82 Severity Value Set Mappings - SNOMED CT to FHIR
....13.83 IPS Bundle example
....13.84 Medication : Simvastatin 40 MG Disintegrating Oral Tablet
....13.85 MedicationStatement: on-going Simvastatin treatment
....13.86 Immunization: Vaccin anti diphtérie-coqueluche-tétanos-poliomyélite (Luxembourg)
....13.87 AllergyIntolerance: No known allergies
....13.88 AllergyIntolerance: resolved allergy
....13.89 Condition: Acute myocardial infarction of anterior wall
....13.90 Procedure: Surgical procedure
....13.91 Practitioner example
....13.92 PractitionerRole: simple example
....13.93 Patient: male patient
....13.94 Patient: minimal example
....13.95 Patient: female patient
....13.96 DeviceUseStatement: No known devices in use
....13.97 Device: No known devices in use
....13.98 Device: device observer example
....13.99 Observation: imaging CT Abdomen W contrast IV
....13.100 Observation: imaging CT Abdomen W contrast IV, sub-observations
....13.101 ImagingStudy: referred DICOM study
....13.102 Organization: example
....13.103 Organization: simple example
....13.104 Organization: lab example
....13.105 Observation: pregnancy edd example
....13.106 Observation: pregnancy status example
....13.107 Observation: pregnancy outcome example
....13.108 Observation: SH tobaccouse example
....13.109 Observation: SH alcoholuse example
....13.110 Specimen: example
....13.111 Observation: serum creatinine example
....13.112 Observation: hemoglobin example
....13.113 Observation: estrogen receptor in tissue example
....13.114 DiagnosticReport: hemoglobin example
....13.115 Media: example